Navigation Links
Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research

BILLERICA, Mass., Dec. 7, 2012 /PRNewswire/ -- Seahorse Bioscience, the world leader in instrumentation and assay kits for measuring cell metabolism announces travel award recipients who presented at the Asia Mito 2012 Conference, November 2-5, 2012, in Beijing.

  • Yu Ting Wu, Ph.D., candidate at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: Regulation of Mitochondrial FoF1ATPase Activity by Sirt3-catalyzed Deacetylation and Its Deficiency Elicited by Oxidative Stress in Cells from Patients with CPEO Syndrome.
  • Chien-Tsun Chen, postdoctoral fellow at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: The Role of Sirtuin 3 and Mitochondria in the Function of Adipocytes Differentiated from Human Mesenchymal Stem Cells.
  • Chih-Hao Wang, postdoctoral fellow at the Institute of Biochemistry and Molecular Biology, National Yang-Ming University, in Taipei, Taiwan. Poster title: Cisd2 deficiency leads to impaired differentiation and function of adipocytes in mice.

Seahorse XF Analyzers and stress test kits are the industry standard for simultaneously measuring the two major energy pathways of the cell - mitochondrial respiration and glycolysis - in a microplate, in real-time. XF Analyzers quickly and easily ensure reliable and reproducible data, revealing a new level of detail regarding the interplay between these energy-producing pathways and disease.

"Increasingly studies reveal that Sirt3 plays a pivotal role in the regulation of mitochondrial metabolism. The XF Analyzer has given us the opportunity to explore how Sirt3 mediates energy homeostasis through deacetylating mitochondrial  proteins, and has enhanced our research by helping us further understand the relationship between the Sirt3 deficiency, and compromised aerobic respiratory in mitochondrial diseases," stated Yu Ting Wu, Ph.D 

Seahorse supports the exploration of cell metabolism through travel awards that are offered to graduate students, post-doctoral researchers, and young investigators who present a poster or presentation citing data generated on the XF platform at scientific meetings and conferences. Through this program, Seahorse seeks to increase the body of knowledge that is enabling new discoveries about the role of cell metabolism in pathophysiology.

"We study the metabolic plasticity of stem cells during the stages of differentiation and reprogramming. The ability to decipher the bioenergetic signatures of stem cells has provided invaluable insight into the regulation of self-renewal and pluripotency," stated Chien-Tsun Chen.

"Advancements in XF technology have made possible significant progress in cellular bioenergetics research. I know, and I believe our customers would agree, that XF Analyzers are now the Gold Standard for studying cell metabolism and its relation to disease," stated Richard Huang, President of Cell-Bio Biotechnology Co. Ltd., Seahorse Bioscience's distributor in Taiwan.

XF technology provides the easiest, most advanced, and comprehensive assessment of cell metabolism available in a microplate today. This knowledge is enabling scientists to better understand the connection of physiological traits of cells with genomic and proteomic data, leading to a greater understanding and new treatments of disease.

About Seahorse Bioscience

Seahorse XF Analyzers and stress test kits are the industry standard in cell metabolism measurements. Scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Cancer, Cardiovascular Disease, Cell Physiology, Immunology, Neurodegeneration, Obesity & Diabetes, Stem Cell Biology, Toxicology, and Translational Medicine. Seahorse is headquartered in Billerica, Massachusetts, U.S., and has offices in Copenhagen, Denmark; and Shanghai, China.

About the National Yang-Ming University

National Yang-Ming University is in the Shipai, Beitou District, Taipei, Taiwan and is known for its academic programs in relation to Medicine, Life Sciences and Biotechnology.

Press Contact:
Cynthia Egan
Director of Marketing
Seahorse Bioscience

SOURCE Seahorse Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
2. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
3. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
4. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
5. Pressure BioSciences Partners with Constant Systems to Significantly Expand Product Offerings and International Distribution
6. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
7. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
8. 3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012
9. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
10. IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility
11. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
Post Your Comments:
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
Breaking Medicine News(10 mins):